Hims & Hers Health, Inc. stock slides 6% as $86.3M loss tests key support

Hims & Hers Health, Inc. stock faces a post-earnings reset after a $86.3 million net loss triggered a 6% after-hours drop. The daily chart, previously neutral near 31.77, is now being repriced by a fresh catalyst. The medium-term structure remains contested.

Key takeaways

• Hims & Hers Health, Inc. stock closed at 31.77 on August 10 before falling 6% after hours on a Q2 net loss of $86.3 million.
• Second-quarter revenue exceeded $753 million, up nearly 40% year over year, with close to 3 million subscribers globally.
• Management raised the 2026 revenue outlook to $3.1–$3.3 billion and guided Q3 revenue to $880–$900 million.
• Key technical levels: resistance at 32.41 (above the 200-day EMA at 32.32), support at 31.02, and secondary support at the 50-day EMA of 30.71.
• Daily ATR of 2.94 signals that wide, unforgiving moves remain the dominant variable for this stock.

Daily structure defines a range, not a trend

The daily chart shows Hims & Hers Health, Inc. stock trapped between short-term recovery and longer-term damage. Price sits above the 20-day EMA at 31.08 and the 50-day EMA at 30.71. However, it remains below the critical 200-day EMA at 32.32. That configuration defines a stock caught between two competing timeframes. Buyers control the near term. Sellers still own the trend line that matters most.

… Continue reading the full article at the original source below.